“access to the production we expect to commence in November this year. So towards the end of the year or early next year we can talk about the transition to the vaccination at least risk groups with subsequent transition to mass vaccination,” said he to the program “Vesti” on TV channel Russia-1.
a Few days ago, the head of Rospotrebnadzor Anna Popova said that the Ministry of health gave permission to conduct clinical studies of the safety and efficacy of the vaccine from COVID-19, developed by “Vector”, and its testing on volunteers has begun.
in addition, the Deputy Prime Minister Tatyana Golikova at a recent meeting on the sanitary-epidemiological situation in Russia with participation of the President of Russia said that under the plan the state registration of the vaccine is to be held in September, and the first commercial batch is expected to produce in October.
.
